<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767856</url>
  </required_header>
  <id_info>
    <org_study_id>HJW1604</org_study_id>
    <nct_id>NCT02767856</nct_id>
  </id_info>
  <brief_title>Regimens of Intermittent Occlusion Therapy for Amblyopia in Children</brief_title>
  <official_title>Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Salus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Salus University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to answer the question: What if the Intermittent Occlusion&#xD;
      (IO-therapy) glasses were prescribed all day (12-hours) in which the total time of treatment&#xD;
      only took 4 weeks instead of the current treatment time (4 hours) in which it takes 12 weeks?&#xD;
&#xD;
      Children aged 3- to 8-years with untreated moderate unilateral amblyopia will be enrolled and&#xD;
      randomized into 2 groups: 1) Intense 12-hour IO-therapy Group for 4 weeks treatment; or 2)&#xD;
      Standard 4-hour IO-therapy glasses Group for 12 weeks treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>4 weeks for the Intense Group and 12 weeks for the Standard Group</time_frame>
    <description>measured with ATS- HOTV method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Randot Preschool Stereoacuity test</measure>
    <time_frame>4 weeks for the Intense Group and 12 weeks for the Standard Group</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Intense 12-hour IO-therapy Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants wear 12-hour daily IO-therapy glasses for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard 4-hour IO-therapy Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants wear 4-hour daily IO-therapy glasses for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IO-therapy Glasses</intervention_name>
    <arm_group_label>Intense 12-hour IO-therapy Group</arm_group_label>
    <arm_group_label>Standard 4-hour IO-therapy Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The following criteria must be met for the patient to be enrolled in the study:&#xD;
&#xD;
          1. Age 3 to &lt; 8 years&#xD;
&#xD;
          2. Unilateral amblyopia associated with strabismus (comitant or incomitant),&#xD;
             anisometropia, or both&#xD;
&#xD;
             Criteria for strabismus: At least one of the following criteria must be met:&#xD;
&#xD;
               -  Heterotropia at distance and/or near fixation on examination (with or without&#xD;
                  spectacles)&#xD;
&#xD;
               -  History of strabismus surgery&#xD;
&#xD;
               -  Documented history of strabismus which is no longer present (which in the&#xD;
                  judgment of the investigator could have caused amblyopia)&#xD;
&#xD;
             Criteria for anisometropia: At least one of the following criteria must be met:&#xD;
&#xD;
               -  &gt;0.50 D difference between eyes in spherical equivalent&#xD;
&#xD;
               -  &gt;0.50 D difference between eyes in astigmatism in any meridian&#xD;
&#xD;
          3. Amblyopic eye has no myopia (&gt; -0.25 D spherical equivalent).&#xD;
&#xD;
          4. Visual acuity, measured in each eye without cycloplegia within 7 days prior to&#xD;
             enrollment using the ATS single-surround HOTV letter protocol as follows:&#xD;
&#xD;
               -  Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive&#xD;
&#xD;
               -  Visual acuity in the sound eye 20/32 or better&#xD;
&#xD;
               -  Inter-eye acuity difference â‰¥ 2 logMAR lines (i.e., amblyopic eye acuity at least&#xD;
                  2 lines worse than sound eye acuity)&#xD;
&#xD;
          5. No previous amblyopia treatment within 6 months.&#xD;
&#xD;
          6. Spectacle correction (if applicable) for measurement of enrollment visual acuity must&#xD;
             meet the following criteria and be based on a cycloplegic refraction within 6 months:&#xD;
&#xD;
               -  Requirements for spectacle correction:&#xD;
&#xD;
               -  For patients meeting criteria for only strabismus&#xD;
&#xD;
                    -  Hypermetropia if corrected must not be undercorrected by more than +1.50 D&#xD;
                       spherical equivalent, and the reduction in plus sphere must be symmetric in&#xD;
                       the two eyes. Otherwise, spectacle correction is at investigator discretion.&#xD;
&#xD;
               -  For patients meeting criteria for anisometropia or combined-mechanism&#xD;
&#xD;
                    -  Spherical equivalent must be within 0.50 D of fully correcting the&#xD;
                       anisometropia&#xD;
&#xD;
                    -  Hypermetropia must not be undercorrected by more than +1.50 D spherical&#xD;
                       equivalent, and reduction in plus must be symmetric in the two eyes&#xD;
&#xD;
                    -  Cylinder power in both eyes must be within 0.50 D of fully correcting the&#xD;
                       astigmatism&#xD;
&#xD;
                    -  Cylinder axis in the spectacle lenses in both eyes must be within 6 degrees&#xD;
                       of the axis of the cycloplegic refraction&#xD;
&#xD;
             Spectacles meeting above criteria must be worn either:&#xD;
&#xD;
               -  for 4 weeks immediately prior to enrollment, or&#xD;
&#xD;
               -  until visual acuity in amblyopic eye is stable (defined as two consecutive visual&#xD;
                  acuity measurements at least 4 weeks apart with no improvement of one line or&#xD;
                  more)&#xD;
&#xD;
               -  An acuity measurement done any of the following ways may be considered the first&#xD;
                  of two consecutive measurements:&#xD;
&#xD;
                    -  in current glasses,&#xD;
&#xD;
                    -  in trial frames with full correction of hypermetropia with cycloplegia, or&#xD;
&#xD;
                    -  in new glasses.&#xD;
&#xD;
          7. Wearing optimal spectacle correction for a minimum of 4 weeks at the time of&#xD;
             enrollment.&#xD;
&#xD;
          8. Ocular examination within 6 months prior to enrollment.&#xD;
&#xD;
          9. Gestational age &gt; 34 weeks and birth weight &gt; 1500 grams&#xD;
&#xD;
         10. Parent willing to accept randomization&#xD;
&#xD;
         11. Parent willing to be contacted and has access to phone&#xD;
&#xD;
         12. Parent does not anticipate relocation outside area within study period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Amblyopic eye has myopia worse than -3.00 D spherical equivalent.&#xD;
&#xD;
          2. Prior intraocular or refractive surgery&#xD;
&#xD;
          3. Ocular pathologies that impact vision&#xD;
&#xD;
          4. Cognitive impairment that prohibits accurate data collection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jingyun Wang, PhD</last_name>
    <phone>2157801376</phone>
    <email>jwang@salus.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Salus University</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingyun Wang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 8, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

